Bridgepoint takes majority stake in Kereis
Context
Bridgepoint has acquired a majority stake in Financière CEP from the American private equity firm JC Flowers & Co and the group's founder, Hubert Guillard. This secondary LBO follows an unsuccessful sale process in 2017. The transaction was secured via a preemptive offer signed in early March 2020, just before the COVID-19 lockdowns. The management team, led by CEO Philippe Gravier, is reinvesting alongside Bridgepoint to support an ambitious growth project. The strategic rationale for the deal is to capitalize on CEP's leadership in the French loan insurance and mortgage brokerage markets. Bridgepoint aims to accelerate the group's digital investments and pursue a strategy of international diversification and product expansion across Europe.
The acquisition of Kereis is part of the growth strategy of Bridgepoint, which already has several external growth operations under its belt, notably Miya Water in 2019.
Kereis, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of 10x–18x.
-> Deep-dive in Financial Services market trends
Target
A European leader in the brokerage of individual protection insurance (especially loan insurance). Kereis provides digital and innovative solutions for banks, insurers, and credit institutions through its specialized subsidiaries.
Ent. Value
€1–10bn
Equity Value
[members only]
Multiples
EV / Revenue
4x–10x
EV / EBITDA
10x–18x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Kereis
Other operations with Bridgepoint
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 02/2023 | BRIDGEPOINT | EQUATIV | FRANCE | AdTech |
| 01/2022 | BRIDGEPOINT | SPARTFIN (PARTNERS FINANCE) | FRANCE | Consumer Credit |
| 01/2019 | BRIDGEPOINT | MIYA WATER | SPAIN | Water |
| 10/2018 | BRIDGEPOINT | HTL BIOTECHNOLOGY | FRANCE | CDMO |
| 01/2017 | BRIDGEPOINT | ZENITH | UNITED KINGDOM | Fleet Management Finance |
| 12/2016 | BRIDGEPOINT | ROVENSA | PORTUGAL | Specialty Chemicals |
| 11/2016 | BRIDGEPOINT | VITAMIN WELL | SWEDEN | Soft Drinks |
| 06/2016 | BRIDGEPOINT / RAISE / FLEXSTONE PARTNERS | ACTEON | FRANCE | Medical Devices |
| 12/2015 | BRIDGEPOINT | ELEMENT MATERIALS TECHNOLOGY | UNITED KINGDOM | TIC (Testing, Inspection, Certification) |
| 01/2015 | BRIDGEPOINT | EFRONT | FRANCE | Financial Services / Banking |
Similar deals in Brokerage
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 03/2021 | GROUPE FINIZY (MEILLEURTAUX) | ACTIVE ASSURANCES | FRANCE | Brokerage |
| 10/2020 | LATOUR CAPITAL | SANTIANE | FRANCE | Brokerage |
| 07/2020 | SILVER LAKE | GROUPE FINIZY (MEILLEURTAUX) | FRANCE | Brokerage |
| 07/2020 | ARDIAN | FINAXY | FRANCE | Brokerage |
| 04/2019 | 21 INVEST | FMA GROUP (FMA ASSURANCES) | FRANCE | Brokerage |
| 01/2019 | CVC | APRIL | FRANCE | Brokerage |
| 02/2018 | ARDIAN | INDEXIA / GROUPE SFAM | FRANCE | Brokerage |
| 01/2017 | GOLDMAN SACHS | GROUPE FINIZY (MEILLEURTAUX) | FRANCE | Brokerage |
| 02/2015 | ARDIAN | SIACI SAINT-HONORE | FRANCE | Brokerage |
| 04/2014 | EQUISTONE | FINAXY | FRANCE | Brokerage |
REFERENCES
Valuation range: EV €1–10bn
Revenue range: €150–250M
EBITDA range: €100–200M
EV/Revenue range: 4x - 10x
EV/EBITDA range: 10x - 18x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Kereis by Bridgepoint are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: kereis
FAQ
What transaction does this page cover?
How was the acquisition of Kereis by Bridgepoint valued, and what multiples were paid?
What were Kereis’s revenue and EBITDA at the time of the deal?
What sources support the information on this transaction?
What is mynth?